Active Ingredient(s): Capsaicin
FDA Approved: * November 16, 2009
Pharm Company: * NEUROGESX, INC.
Category: Sexual Health

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Qutenza Overview

Capsaicin (8-methyl-N-vanillyl-6-nonenamide) is an active component of chili peppers, which are plants belonging to the genus Capsicum. It is a chemical irritant for mammals, including humans, and produces a sensation of burning in any tissue with which it comes into contact. Capsaicin and several related compounds are called capsaicinoids and are produced as secondary metabolites by chili peppers, probably as deterrents against certain mammals and fungi.[4] Pure capsaicin is ...

Read more Qutenza Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Capsaicin

Recent Qutenza Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Cream: 0.025%, 0.075%, 0.25%
  • Gel: 0.025%, 0.075%
  • Lotion: 0.025%, 0.075%
  • Patch: 8%
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Qutenza: (5 results)

Sorted by National Drug Code
  • 10144-928 Qutenza Kit by Acorda Therapeutics, Inc.
  • 10144-929 Qutenza Kit by Acorda Therapeutics, Inc.
  • 49685-928 Qutenza Kit by Neurogesx, Inc.
  • 72512-928 Qutenza Kit by Averitas Pharma Inc
  • 72512-929 Qutenza Kit by Averitas Pharma Inc

Other drugs which contain Capsaicin or a similar ingredient: (13 results)

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 11 April 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA